Efficacy and Safety of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis: Results From TRuE-AD4, a Phase 3b, Randomized, Double-Blind, Vehicle-Controlled Study
Por:
Carrascosa, JM, Prajapati, VH, Hong, HCH, Eleftheriadou, V, Tsianakas, A, Navarini, A, Peris, K, Song, EJ, Chovatiya, R, Barbarot, S, Popovic, K, Nawaz, H, Li, Q and Wollenberg, A
Publicada:
1 feb 2026
Resumen:
Filiaciones:
:
Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IGTP, Badalona, Spain
Prajapati, VH:
Univ Calgary, Calgary, AB, Canada
Dermatol Res Inst, Calgary, AB, Canada
Skin Hlth & Wellness Ctr, Calgary, AB, Canada
Prob Med Res, Calgary, AB, Canada
Hong, HCH:
Univ British Columbia, Vancouver, BC, Canada
Prob Med Res, Surrey, BC, Canada
Eleftheriadou, V:
Royal Wolverhampton NHS Trust, Wolverhampton, England
Univ Birmingham, Coll Med & Hlth, Birmingham, England
Walsall Healthcare NHS Trust, Walsall, England
Tsianakas, A:
Fachklin Bad Bentheim, Bad Bentheim, Germany
Navarini, A:
Univ Hosp Basel, Basel, Switzerland
Peris, K:
Univ Cattolica Sacro Cuore, Rome, Italy
Song, EJ:
Frontier Dermatol, Mill Creek, WA USA
Chovatiya, R:
Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL USA
Ctr Med Dermatol Immunol Res, Chicago, IL USA
Barbarot, S:
Nantes Univ, Ctr Hosp Univ Nantes, Nantes, France
Popovic, K:
Incyte Biosci Int Sarl, Morges, Switzerland
Nawaz, H:
Incyte Corp, Wilmington, DE USA
Li, Q:
Incyte Corp, Wilmington, DE USA
Wollenberg, A:
Univ Hosp Augsburg, Augsburg, Germany
Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany
Ludwig Maximilians Univ Munchen, Munich, Germany
|